(Q3 Un-audited): As per life revenue account of the company for July to September, 2026, excess of total expenses including claims over total income (deficit) was BDT 607.89 million as against excess of total expenses including claims over total income (deficit) of BDT 70.42 million in the corresponding previous period of 2025. Whereas as per life revenue account of the company for January to September, 2026, excess of total expenses including claims over total income (deficit) was BDT 1,206.17 million as against excess of total expenses including claims over total income (deficit) of BDT 1,021.17 million in the corresponding previous period of 2025. Accordingly, Balance of Life Insurance Fund was BDT 6,190.84 million as on September 30, 2026 as against BDT 6,470.73 million as on September 30, 2025 resulting a net decrease of BDT 279.89 million.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2026 at 3:30 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended September 30, 2026.

The company has requested to update the Bank Accounts, Address, Mobile number, 12 digits e-TIN number through their respective DP as per Record Date 16/07/2026. The company has also requested the Merchant Banks and Brokerage Houses to provide a statement with details (Shareholders' name, BO ID number, 12-digit e-TIN Number, Number of shares held, Gross dividend receivable, applicable tax rate) of their margin loan holders who hold shares of the Company on the record date along with the name and mobile number of the contact person within July 30, 2026 and soft data to the e-mail address: share@primeislamilife.com.

Trading of the shares of the company will resume on 19.07.2026.

The board of directors of the company has approved valuation report as at December 31, 2024. As per the valuation report, the Net Liability stood at Tk. 13,469,059,320.00 as at December 31, 2024 as against Tk. 14,267,801,247.00 as at December 31, 2023. The Balance of Life Insurance Fund as shown in the balance sheet was Tk. 7,491,907,036.00 as at December 31, 2024 as against Tk. 7,573,495,801.00 as at December 31, 2023. The company reported a deficit of Tk. 5,977,152,284.00 as at December 31, 2024 as against a Deficit of Tk. 6,694,305,446.00 as at December 31, 2023.

Trading of the shares of the company will remain suspended on record date i.e., 16.07.2026.

(Q2 Un-audited): As per consolidated life revenue account of the company for April to June, 2026, excess of total expenses including claims over total income (deficit) was BDT 21.59 million as against excess of total expenses including claims over total income (deficit) of BDT 206.22 million in the corresponding previous period of 2025. Whereas as per consolidated life revenue account of the company for January to June, 2026, excess of total expenses including claims over total income (deficit) (Continuation news of PRIMELIFE): was BDT 598.27 million as against excess of total expenses including claims over total income (deficit) of BDT 950.75 million in the corresponding previous period of 2025. Balance of Life Insurance Fund was BDT 6,798.74 million as on June 30, 2026 as against BDT 6,541.15 million as on June 30, 2025 resulting a net increase of BDT 257.59 million.

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 14.07.2026 to 15.07.2026 and trading of the shares will remain suspended on record date i.e., 16.07.2026.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 14, 2026 at 3:30 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.

The auditor of the company has given the Qualified Opinion, Emphasis of Matter and Other Matters paragraph in the auditor's report for the year ended December 31, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/PRIMELIFE.pdf